1397-P: Description of Prescribing Patterns of Antihyperglycemic Medications among Racially and Ethnically Diverse Populations in the All of Us Dataset

Introduction 7% (57.2%). Blacks (aOR = 0.72, 95% CI: 0.66 - 0.79) and Hispanics (aOR = 0.81, 95% CI: 0.73 - 0.90) compared to White participants were less likely to receive GLP1-RA prescription. Additionally, Blacks were less likely to receive SGLT2i (aOR = 0.86, 95% CI: 0.78-0.96) but more likely to receive metformin (aOR = 1.33, 95% CI: 1.21-1.45). Blacks (aOR = 0.81, 95% CI: 0.74 - 0.88) and Hispanics (aOR = 0.75, 95% CI: 0.68 - 0.83) were less likely to receive insulin therapy. Conclusions: Our findings, highlight racial and ethnic disparities in prescribing patterns. These findings provide evidence that these differences are independent of socioeconomic status and may be a factor in worse health outcomes experienced by racial minorities with T2D. Disclosure V.J. Brady: Board Member; Association of Diabetes Care Diathrive. S. Akyirem: None. N. Padhye: None. Funding American Association of Colleges of Nursing (AACN)